Atrial fibrillation is not uncommon in the general population and is associated with a significant deterioration in quality of life and increased cardiovascular morbidity and mortality. Atrial fibrillation and coronary heart disease can coexist: 17-47% of patients with atrial fibrillation also have coronary heart disease, and 1-5% of patients with coronary heart disease also have atrial fibrillation.
Kadyrova F. et al. Поширенiсть бессимптомно гiперурикемii серед хворих з iшемiчною хворобою //Здобутки клінічної і експериментальної медицини. – 2017. – №. 2.
Насырова З. А., Абдуллоева М. Д., Усаров Ш. А. У. СТРАТИФИКАЦИЯ ФАКТОРОВ РИСКА ПРИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА //Journal of cardiorespiratory research. – 2021. – Т. 1. – №. 3. – С. 14-17.
Ташкенбаева Э. Н., Насырова З. А., Тоиров А. Э. Течение нестабильных вариантов стенокардии при полиморбидных состояниях //Colloquium-journal. – Голопристанський міськрайонний центр зайнятості= Голопристанский районный центр занятости, 2019. – №. 27-3. – С. 45-49.
Элламонов С. Н. и др. Факторы прогрессирования артериальной гипертензии у больных в коморбидности с сахарным диабетом 2 типа //Journal of cardiorespiratory research. – 2021. – Т. 1. – №. 2. – С. 16-21.
Saito S, Teshima Y, Fukui A et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5–14. https://doi.org/10.1093/cvr/cvu176
Schmitt J, Duray G, Gersh B et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045.
Schnabel RB, Yin X, Gona P et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–162. https://doi.org/10.1016/S0140-6736(14)61774-8
Shanmugasundaram M, Paul T, Hashemzadeh M et al. Outcomes of percutaneous coronary intervention in atrial fibrillation patients presenting with acute myocardial infarction: analysis of nationwide inpatient sample database. Cardiovasc Revasc Med. 2020;21(7):851–854.
Shiga T, Wajima Z, Inoue T, et al. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med. 2004;117:325–333.
Simmers MB, Cole BK, Ogletree ML et al. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thromb Res. 2016;143:34–39.
Soliman EZ, Lopez F, O’Neal WT et al. Atrial fibrillation and risk of ST-segment–elevation versus non–ST-segment–elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;131(21):1843–1850.
Steinberg JS, Zelenkofske S, Wong SC, et al. Value of P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 2017;88:2618–2622
Tanigawa M, Fukatani M, Konoe A, et al. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrilla-tion and sinus sick node syndrome. J Am Coll Cardiol. 2018;17:403–408.
Tereshchenko LG, Rizzi P, Mewton N et al. Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. Int J Cardiol. 2014;172(1):196–201.
Toh N, Kanzaki H, Nakatani S et al. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension. 2020;55:1150– 1156. https://doi.org/10.1161/HYPERTENSIONAHA.109.137760
van Diepen S, Siha H, Fu Y et al. Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. J Electrocardiol. 2021;43(4):351–358. https://doi. org/10.1016/j.jelectrocard.2010.04.001
Vilani GQ, Piepoli M, Cripps T, et al. Atrial late potentials in patients with paroxysmal atrial fibrillation detected using a high gain, signal-averaged esophageal lead. PACE. 2016;17:1118–1123.
Villareal R, Hariharan R, Liu B, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–748.
Violi F, Soliman EZ, Pignatelli P et al. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. 2016;5(5):e003347. https://doi.org/10.1161/JAHA.116.003347
Wang J, Yang YM, Zhu J. Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome. Herz. 2015;40(S1):18–26. https://doi.org/10.1007/s00059-014-4149-3
Wong CX, Sullivan T, Sun MT et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1(3):139–152. https://doi.org/10.1016/j.jacep.2015.04.004
Yamada T, Fukunami M, Shimonagata T, et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J.2018;20:211–220.